Argos Therapeutics Inc (NASDAQ:ARGS)

8.84
Delayed Data
As of Mar 26
 -0.08 / -0.90%
Today’s Change
5.61
Today|||52-Week Range
11.11
-11.60%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close8.92
Today’s open8.90
Day’s range-- - --
Volume57,364
Average volume (3 months)53,455
Market cap$175.3M
Dividend yield--
Data as of 03/26/2015

Growth & Valuation

Earnings growth (last year)-436.28%
Earnings growth (this year)+98.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.18%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CNDOCoronado Biosciences...-0.04-1.04%
MSLIMerus Labs Internati...-0.12-5.29%
SNSSSunesis Pharmaceutic...-0.08-3.17%
SYNSynthetic Biologics ...+0.04+1.72%
Data as of 03/26/2015

Financials

Next reporting dateMarch 31, 2015
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$4.4M
Annual profit (last year)-$23.9M
Net profit margin-541.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account